Another 3 Common Pesticides Are Now Linked To Parkinson’s Disease Risk

Translate to Spanish or other 102 languages!

Three more pesticides commonly used in the United States have now been linked to heightened Parkinson’s risk. Image for illustration purposes
Three more pesticides commonly used in the United States have now been linked to heightened Parkinson’s risk. Image for illustration purposes
- Advertisement -
  • Parkinson’s disease prevalence is growing fast, and similar to some other neurological conditions, its causes are unclear. 
  • The potential impact of chemicals that are toxic to neurons in the part of the brain affected by Parkinson’s disease has been investigated since the 1980s. 
  • Despite this, many chemicals, particularly pesticides and herbicides that are known to pose a risk, are still used in many parts of the world. 
  • Researchers have now identified a risk of Parkinson’s disease associated with exposure to 14 pesticides. 

Parkinson’s disease is the fastest growingTrusted Source neurological disorder in the world at present, and the reason why is unclear.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/another-3-common-pesticides-are-now-linked-to-parkinsons-disease-risk?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-03-11&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

Golden Years, Restless Nights: How Aging Transforms Your Sleep Cycles

If you have trouble falling asleep or staying asleep, your age could be playing a role.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral’s Webinar on Suicide Prevention Awareness, Sept. 3rd

More than 49,000 people died by suicide in the United States in 2023, according to the Centers for Disease Control and Prevention (CDC), making it one of the leading causes of death among adolescents and adults.
- Advertisement -